Under homeostatic conditions, the p16 INK4a acts as a tumor suppressor by inactivating the cyclin-dependent kinases that phosphorylate the retinoblastoma protein (pRb) and thereby hamper the cell cycle progression from G1 to the S phase of mitosis. The gene discussed is CDKN2A; the disease is neoplasm.